Common use of Material Adverse Effect on the Company Clause in Contracts

Material Adverse Effect on the Company. No Material Adverse Effect on the Company shall have occurred since the date of this Agreement, and there shall not have occurred any change, event, development, state of facts, effect or occurrence that has had, or would reasonably be expected to have, a Material Adverse Effect.

Appears in 3 contracts

Sources: Merger Agreement (Usa Technologies Inc), Merger Agreement (Ligand Pharmaceuticals Inc), Merger Agreement (Ligand Pharmaceuticals Inc)

Material Adverse Effect on the Company. No Material Adverse Effect on the Company shall have occurred since Since the date of this Agreementhereof, and there shall not have occurred been any changeeffect, eventchange or development that, developmentindividually or in the aggregate with other such effects, state of factschanges or developments, effect or occurrence that has had, or would reasonably be expected likely to have, a Company Material Adverse Effect.

Appears in 2 contracts

Sources: Combination Agreement (Donnelley R R & Sons Co), Combination Agreement (Moore Wallace Inc)

Material Adverse Effect on the Company. No Material Adverse Effect on the Company shall have occurred since Since the date of this Agreement, and there shall not have occurred any effect, change, event, developmentoccurrence, state of factscircumstance or development that, effect individually or occurrence that in the aggregate, has had, or would reasonably be expected to have, a Material Adverse EffectEffect on the Company.

Appears in 1 contract

Sources: Merger Agreement (National Dentex Corp /Ma/)

Material Adverse Effect on the Company. No Material Adverse Effect on the Company shall have occurred since the date of this Agreement, and there shall not have occurred any change, event, development, state of facts, effect or occurrence that has had, or would reasonably be expected to have, a Material Adverse EffectEffect on the Company.

Appears in 1 contract

Sources: Agreement and Plan of Merger (Aratana Therapeutics, Inc.)